J&J Vaccine Pause Shows Challenges Still Ahead for Covid-19 Shots

The suspension of Johnson & Johnson’s trials poses another setback for global efforts to develop a shot to protect lives and jump-start economies battered by the pandemic, as well as a reminder of the challenges of fast-tracking vaccine development.

Read the full article here

Related Articles